Uridine 5'-triphosphate Completed Phase 3 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00210080A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)